By Brendan Pierson, Published on
Reuters on September 8th, 2015
New York – Pacira Pharmaceuticals Inc on Tuesday filed a lawsuit seeking a court order allowing it to promote its post-surgery pain drug, Exparel, for a wide range of surgeries, which the U.S. Food and Drug Administration opposes. [
Read More ]
Related Event:
ACI is pleased to bring you our summit on Drug and Device Advertising and Promotional Review Compliance on January 11-13, 2016 in Philadelphia, PA. Designed from industry input, this advanced program will help you understand the best practices in advertising and promotions from the nation’s top companies.
Click here to learn more.
Tags: Industry news, Pharmaceutical, Promotional Review Compliance for Drugs and Devices